Jake Chabon

Co-founder CEO @Foresight Diagnostics A Natera Company

Denver, CO, US
EMAILS
j••••••••@foresight-dx.com
MOBILE NUMBERS
+13•••••••94

Signup · Get unlimited contacts

WORK HISTORY

Oct 2020 — Present

Co-founder CEO @Foresight Diagnostics A Natera Company

View department →

Foresight Diagnostics is an early-stage, venture-backed molecular diagnostics company that is developing non-invasive cancer detection technologies to improve the lives of patients worldwide. Our portfolio of cell-free DNA based liquid biopsy tests are rooted in novel and proprietary methods developed at Stanford University. Our approach enables the earlier detection of smaller tumors, leading to more personalized and effective cancer treatment strategies for patients. We have deep expertise in molecular biology, bioinformatics, and Next Generation Sequencing (NGS).

EDUCATION

2013 — 2018

Stanford University

Doctor of Philosophy - PhD, Stem Cell Biology and Regenerative Medicine

2006 — 2010

University of Denver

BS, Molecular Biology, Pre-med. Triple Minor in Business Administration, Chemistry, & Psychology.

SKILLS

LifesciencesData AnalysisMolecular BiologyCell CulturePcrImmunohistochemistryHistologyWestern BlottingResearchBiotechnology

ABOUT JAKE CHABON

I am molecular biologist and bioinformatic scientist with a passion for entrepreneurship.…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.